Press Release

PhRMA Applauds Sebelius Nomination for HHS Secretary

PhRMA March 2, 2009

Washington, D.C. (March 2, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today on Kathleen Sebelius’ selection as incoming Department of Health and Human Services Secretary:

“Kansas Gov. Kathleen Sebelius is a wise choice to guide the President on shaping healthcare reform. Gov. Sebelius combines the vital combination of skills that it will take to accomplish this challenging job: Toughness and an intimate understanding of the healthcare challenges that face our nation in these tough economic times.

“Already, President Obama has signaled the importance of healthcare reform for this new administration. PhRMA, among the attendees at this week’s healthcare reform summit, stands ready to work meaningfully with the Administration and Congress on this challenge.

“What’s more, America’s pharmaceutical research and biotechnology companies – which lead the world in discovering new cures and treatments for patients – welcome the opportunity to make real President Obama’s desire to discover a cure for cancer in our lifetime. Healthcare reform will balance the necessity of extending healthcare to all Americans while maintaining an environment conducive to innovation that will lead to cures for cancer and other ailments.

“PhRMA is committed to working with lawmakers on both sides of the aisle and will continue to support policies that encourage and strengthen innovation, improve patient access to medicines and expand healthcare coverage for all Americans.”


The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address:

For information on how innovative medicines save lives, visit:

For information on the Partnership for Prescription Assistance, visit:

For information on the danger of imported drugs, visit: